Search results

101. Nanoparticles of gold, gold-gold sulfide and titanium dioxide modified with tellurium as carriers for At-211 for targete…

Principal investigator: prof. Aleksander Józef Bilewicz

Instytut Chemii i Techniki Jądrowej

Call: OPUS 6, Panel: ST4

102. Photoactive nanliposome-based formulation as a new strategy in photodynamic therapy of atherosclerotic plaque

Principal investigator: dr hab. Marta Kopaczyńska

Politechnika Wrocławska, Wydział Podstawowych Problemów Techniki

Call: OPUS 5, Panel: NZ5

103. Theranostic GdLip: Bifunctional liposomes as carriers of gadolinium ions and phthalocyanine photosensitizers for potenti…

Principal investigator: dr Łukasz Dariusz Sobotta

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: PRELUDIUM 4, Panel: NZ7

104. Renal denervation in patients with chronic heart failure and resynchronization therapy.

Principal investigator: prof. Danuta Czarnecka

Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum; Wydział Lekarski

Call: OPUS 4, Panel: NZ5

105. DNA double-stranded break repair proteins as a target for personalized cancer therapy based on synthetic lethality

Principal investigator: dr hab. Tomasz Śliwiński

Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

Call: OPUS 4, Panel: NZ7

106. PTSD: Diagnosis, therapy, prevention.

Principal investigator: prof. Bogdan Włodzimierz Zawadzki

Uniwersytet Warszawski, Instytut Studiów Społecznych im. prof. Roberta B. Zajonca

Call: MAESTRO 3, Panel: HS6

107. Natural products derived from Chelidonium majus plant as potecial photosensitisers for the photodynamic therapy (PDT) of…

Principal investigator: dr Alicja Warowicka

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

Call: PRELUDIUM 3, Panel: NZ9

108. Polymeric biomaterials doped with peripherally modified porphyrazines of potential usage in photodynamic therapy

Principal investigator: dr Jarosław Tomasz Piskorz

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: PRELUDIUM 3, Panel: NZ7

109. Influence of PPAR-gama receptor agonists on antitumor activity of photodynamic therapy.

Principal investigator: dr Piotr Marek Mrówka

Warszawski Uniwersytet Medyczny, Wydział Nauki o Zdrowiu

Call: PRELUDIUM 3, Panel: NZ5

110. The importance of pharmacogenetic factors in the individualization of therapy using immunosuppressive drugs in kidney tr…

Principal investigator: dr Anna Bogacz

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Call: OPUS 2, Panel: NZ7

111. Combination therapy with naphthoquinones and paclitaxel in the pharmacological induction of cell death in breast cancer …

Principal investigator: dr Anna Kawiak

Uniwersytet Gdański

Call: OPUS 2, Panel: NZ7

112. Regulation of ALKBH proteins expression in cancer and its role in cancer therapy.

Principal investigator: prof. Elżbieta Grzesiuk

Instytut Biochemii i Biofizyki PAN

Call: OPUS 2, Panel: NZ4

113. Pathogenesis of ovarian cancer survival in non-adhesion conditions: transcriptomic assessment and studies of molecular t…

Principal investigator: dr Anna Stachurska

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

Call: PRELUDIUM 2, Panel: NZ1

114. Activity evaluation of procaryotic TA modules in a dual-component model of cancer therapy

Principal investigator: Łukasz Janusz Wieteska

Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu; Zakład Biochemii Medycznej

Call: PRELUDIUM 2, Panel: NZ5

115. Synthesis of new phthalocyanines for targeted photodynamic cancer therapy.

Principal investigator: dr Łukasz Andrzej Łapok

Uniwersytet Jagielloński, Wydział Chemii; Zespół Nanotechnologii Polimerów i Biomateriałów

Call: SONATA 2, Panel: ST5

116. The role of free radicals and singlet oxygen in phototoxicity and photodynamic therapy (PDT) of tumors and bacterial inf…

Principal investigator: prof. Tadeusz Sarna

Uniwersytet Jagielloński, Wydział Biochemii, Biofizyki i Biotechnologii

Call: OPUS 2, Panel: NZ1

117. Visual creation in art therapy as a space for personal development: theoretical and empirical aspects of creative worksh…

Principal investigator: prof. Eugeniusz Andrzej Józefowski

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Pedagogiczno-Artystyczny w Kaliszu

Call: OPUS 2, Panel: HS2

118. Discovery and development of small-molecule inhibitors of USP2 for targeted, non-genotoxic therapy of cancer

Principal investigator: prof. Tadeusz Andrzej Holak

Uniwersytet Jagielloński, Wydział Chemii

Call: OPUS 1, Panel: ST5

119. New drug carriers in targeted anticancer therapy

Principal investigator: prof. Artur Piotr Terzyk

Uniwersytet Mikołaja Kopernika, Wydział Chemii

Call: OPUS 1, Panel: ST5

120. The effect of tactile sensations on attentional processes - working mechanisms in the context of art therapy

Principal investigator: Maja Stańko-Kaczmarek

Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Nauk Społecznych

Call: PRELUDIUM 1, Panel: HS6

121. Spiritual and religious coping and biopsychosocial functioning of alcohol-dependent individuals participating in cogniti…

Principal investigator: Edyta Charzyńska

Szkoła Wyższa Psychologii Społecznej w Warszawie

Call: PRELUDIUM 1, Panel: HS6

122. Iron chelators- the novel approach to anticancer therapy

Principal investigator: Maciej Michał Serda

UNIWERSYTET ŚLĄSKI, Wydział Matematyki Fizyki i Chemii

Call: PRELUDIUM 1, Panel: NZ4

123. Nanozeolites as a carriers of radium radionuclides in targeted therapy.

Principal investigator: prof. Aleksander Józef Bilewicz

Instytut Chemii i Techniki Jądrowej

Call: HARMONIA 1, Panel: ST4

124. Machine Learning Platform for Personalized Intravitreal Anti-VEGF Therapy Using Drug-Loaded Polymeric Nanoparticles

Principal investigator: dr Marcin Krzysztof Heljak

Politechnika Warszawska

Call: M-ERA.NET 3 Call 2025, Panel: ST11

125. The stabilization mechanism and dissolution kinetics of co-amorphous systems - a new perspective on enhancing the effica…

Principal investigator: Agata Olszewska

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: PRELUDIUM 24, Panel: ST5

126. Phosphorylation-Dependent Regulation of IRS2 by DYRK1A: Implications for Diabetes Therapy

Principal investigator: Alicja Bis

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ1

127. Effect of dietary modulation of RAGE/AGE axis on prostatic neuroendocrine differentiation and the efficacy of anticancer…

Principal investigator: dr Wawrzyniec Dobrucki

Gdański Uniwersytet Medyczny

Call: OPUS 29, Panel: NZ7

128. Pharmacokinetic and pharmacodynamics modeling of antidepressants in a mechanistic approach for efficient therapy.

Principal investigator: prof. Filip Rybakowski

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: OPUS 29, Panel: NZ7

129. Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat…

Principal investigator: dr hab. Robert Czarnomysy

Uniwersytet Medyczny w Białymstoku

Call: OPUS 29, Panel: NZ7

130. The Impact of Endocannabinoid System Modulation and Enriched Environment on the Therapy of Myelination and Memory Disord…

Principal investigator: Justyna Anna Socha

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 24, Panel: NZ5

131. Personalized selective activation of γδT Vδ2 cells using zoledronic acid for glioblastoma MICA/Bhigh therapy: in vitro a…

Principal investigator: Natalia Anna Lehman

Uniwersytet Medyczny w Lublinie

Call: PRELUDIUM 24, Panel: NZ4

132. Immersive virtual reality therapy combined with guided breathing exercises as a supportive intervention for reducing dep…

Principal investigator: Magdalena Anna Nowak

Politechnika Opolska

Call: PRELUDIUM 24, Panel: NZ7

133. Molecular Pathogenesis and Precision Antisense Oligonucleotide Therapy for BAG3-Related Myofibrillar Myopathy Type 6 Usi…

Principal investigator: dr Estera Elmira Rintz

Uniwersytet Gdański

Call: OPUS 29, Panel: NZ2

134. UVC Persistent Phosphors for Next-Generation Photodynamic Cancer Therapy

Principal investigator: dr Nadiia Rebrova

Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

Call: OPUS 29, Panel: ST4

135. Disrupting the Toxic NMDAR/TRPM4 Protein Dialogue as a Novel Neuroprotective Strategy: Development of Small-Molecule Inh…

Principal investigator: Katarzyna Aleksandra Szafrańska

Uniwersytet Jagielloński

Call: PRELUDIUM 24, Panel: NZ7

136. Photoactive, supramolecular, and biocompatible materials suitable for antimicrobial photodynamic therapy

Principal investigator: dr Dorota Anna Chełminiak-Dudkiewicz

Uniwersytet Mikołaja Kopernika

Call: WEAVE-UNISONO, Panel: ST5

137. Unravelling the Mechanisms of Streptococcus agalactiae Tolerance to Oxidative Stress as the Key to Developing Modern The…

Principal investigator: dr Michał Karol Pierański

Politechnika Gdańska

Call: SONATINA 9, Panel: NZ7

138. The role of DNA methylation in therapy that increases CFTR channel activity in cystic fibrosis

Principal investigator: dr Beata Maria Narożna

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

Call: SONATA 20, Panel: NZ5

139. The role of structural changes of lung surfactants in pulmonary diseases – from physicochemical description to effective…

Principal investigator: dr hab. Dorota Matyszewska

Uniwersytet Warszawski

Call: OPUS 28, Panel: ST4

140. Janus nanoparticles - research on the effect of the duality of carriers of the activesubstance in targeted therapy of sk…

Principal investigator: dr hab. Bożena Anna Tyliszczak

Politechnika Krakowska im. Tadeusza Kościuszki

Call: OPUS 28, Panel: ST8

141. The influence of beta2-receptor N-terminal polymorphismsadrenergic on its functionality, interactions withdrugs and the …

Principal investigator: dr hab. Anita Elżbieta Płazińska

Uniwersytet Medyczny w Lublinie

Call: OPUS 28, Panel: NZ7

142. Prolonged-release of selected antiangiogenic proteins from innovative nanocarrier for use in adjuvant/additive multiple …

Principal investigator: prof. Bogusław Bronisław Machaliński

Pomorski Uniwersytet Medyczny w Szczecinie

Call: OPUS 28, Panel: NZ7

143. Cannabidiol as a Neuroprotective Therapy: Are Brain Regeneration Mechanisms After Perinatal Hypoxia-Ischemia Sex-Depende…

Principal investigator: dr Hanna Kletkiewicz

Uniwersytet Mikołaja Kopernika

Call: SONATA 20, Panel: NZ7

144. Combating Hypoxia to prevent Right Ventricular Failure in experimental pulmonary hypertension - role of energetics, fibr…

Principal investigator: dr hab. Michał Maria Mączewski

CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

Call: OPUS 28, Panel: NZ4

145. Decoding the novel role of the histamine H3 receptor in opioid-induced analgesia and hyperalgesia: studies toward innova…

Principal investigator: dr Katarzyna Popiołek-Barczyk

Instytut Farmakologii PAN

Call: OPUS 28, Panel: NZ7

146. Neutrophil Dynamics: Unveiling Anti-Tumor and Therapy Efficacy with the TUmor Neutrophil Immunotherapy on Chip (TUNIC) m…

Principal investigator: dr Martin Nurmik

Międzynarodowy Instytut Mechanizmów i Maszyn Molekularnych Polskiej Akademii Nauk

Call: SONATA 20, Panel: NZ6

147. Human exosomes as natural carriers of protein kinase CK2 inhibitors and degraders in targeted anticancer therapy.

Principal investigator: dr hab. Patrycja Joanna Wińska

Politechnika Warszawska

Call: OPUS 28 (LAP), Panel: NZ5

148. Biomimetic scaffolds modified with ferulic acid dedicated to necrotic wound therapy

Principal investigator: dr Beata Kaczmarek-Szczepańska

Uniwersytet Mikołaja Kopernika

Call: SONATA 20, Panel: NZ7

149. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud…

Principal investigator: prof. Gabriel Piotr Nowak

Instytut Farmakologii PAN

Call: OPUS 28, Panel: NZ7

150. The first antibody-drug conjugates for Alzheimer's disease therapy

Principal investigator: dr hab. Marcin Łukasz Poręba

Politechnika Wrocławska

Call: SONATA BIS 14, Panel: NZ5

Projects search